Dover’s CPC Biotech Launches High-Flow Sterile Disconnect for Bioprocessing
Event summary
- CPC Biotech, a Dover subsidiary, introduced the RevolveSD™ Series, a one-inch flow path, single-use sterile disconnect for bioprocessing.
- The product enables sterile disconnection of bioprocess tubing in fewer steps than traditional methods, reducing setup time and preventing unintended reconnection.
- RevolveSD is made of polyphenylsulfone (PPSU), compatible with harsh chemicals used in applications like antibody drug conjugate manufacturing.
- The series features dual-valve, non-spill technology that minimizes residual fluid and supports smooth bidirectional flow.
The big picture
Dover’s launch of the RevolveSD Series underscores the growing demand for efficient, sterile disconnection solutions in large-scale bioprocessing. The product aligns with industry trends toward single-use systems and streamlined manufacturing processes, potentially reducing downtime and improving yield in biologics production.
What we're watching
- Adoption Pace
- How quickly bioprocessors will integrate the RevolveSD Series into their operations, given its claimed efficiency advantages.
- Competitive Response
- Whether competitors like those behind AseptiQuik Series connectors will introduce similar high-flow sterile disconnects.
- Market Expansion
- The extent to which Dover can leverage this innovation to expand its footprint in the biopharmaceutical processing sector.
Related topics